Compression Therapy Market is expected to reach US$ 3.44 Billion by 2034

Compression Bandages Segment Leading the Compression Therapy Market by Product

According to our new research study on “Compression Therapy Market Forecast to 2034 – Global Analysis – by Product, Technology, Application, and End User,” the compression therapy market size is expected to grow from US$ 2.39 billion in 2025 to US$ 3.44 billion by 2034, with a CAGR of 4.2% during 2026–2034. The major factors that are driving the compression therapy market growth are the rising prevalence of venous and lymphatic disorders driving therapy adoption, technological advancements and product innovations, and aging populations and increasing chronic disease.

The global compression therapy market experiences expansion because more people develop venous and lymphatic disorders that require medical compression products for the treatment of deep vein thrombosis (DVT), chronic venous insufficiency (CVI), varicose veins, and lymphedema. The US Centers for Disease Control and Prevention (CDC) states that ~900000 Americans develop venous thromboembolism (VTE) each year, which includes both DVT and pulmonary embolism, and 60000 to 100000 Americans die from these events every year; efforts to prevent these complications involve compression therapy such as stockings or pneumatic devices. According to large population studies and international vascular and phlebology guidelines, 30–40% of adults worldwide show signs of chronic venous disease, with prevalence rising to over 50% in those aged 65 and above, highlighting the broad global patient pool. The developed and developing regions of the world show a high population rate of chronic venous insufficiency, which leads to the development of venous leg ulcers, edema, and pain. The clinical guidelines identify these conditions as medical reasons to use compression therapy, as they decrease circulatory efficiency and increase swelling reduction. The healthcare system in North America, Europe, and Asia Pacific will experience rising demand for compression solutions as the aging population will increase the number of people who develop venous disorders during the upcoming years.

Compression Therapy Market, by Region, 2025 (%)

Source: The Insight Partners Analysis

Compression Therapy Market Analysis Based on Segmental Evaluation:

Based on product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression sleeves, compression tape, compression braces, compression pumps, and other products. In 2025, the compression bandages segment held a significant compression therapy market share. The compression bandages segment holds a dominant share in the compression therapy market owing to its widespread clinical use in managing venous leg ulcers, lymphedema, and chronic venous insufficiency. These bandages are widely preferred in hospitals and wound care centers as they provide adjustable pressure, are cost-effective, and can be applied for different stages of treatment. Healthcare professionals often recommend compression bandages for initial therapy and post-surgical recovery due to their effectiveness in improving blood circulation and reducing swelling. The increasing prevalence of chronic wounds and vascular disorders, along with rising demand for affordable treatment solutions in both developed and emerging markets, continues to drive growth in this segment.

The scope of the compression therapy market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa. In terms of revenue, North America dominated the compression therapy market share in 2025. The US compression therapy market is expanding due to high and sustained prevalence of vascular and lymphatic conditions, evolving policy coverage, and continued clinical innovation. According to the CDC, venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, affects up to 900,000 Americans annually, with many cases preventable through mechanical measures such as compression therapy, highlighting a large at-risk population requiring clinical management. Chronic venous insufficiency (CVI), a major indication for compression products, is estimated to affect between 10% and 35% of US adults, with complications such as venous ulcers more common in older adults. Lymphedema also remains prevalent, with at least five million Americans living with the condition, and roughly half of them covered under Medicare Part B starting in 2024 for medically prescribed compression garments and supplies, according to the Centers for Medicare & Medicaid Services (CMS). 

Solventum Corporation, Enovis Corp, Convatec Inc, Arjo AB, Hartmann, Essity AB, Juzo, SIGVARIS GROUP, medi Canada Inc, Lohmann & Rauscher GmbH & Co KG, and Paul Hartmann AG are among the leading companies profiled in the compression therapy market report.   

Based on product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression sleeves, compression tape, compression braces, compression pumps, and other products. Based on technology, the market is segmented into static compression therapy and Dynamic compression therapy. Based on application, the market is segmented into leg ulcer, deep vein thrombosis, varicose veins, lymphedema, lipedema, and other applications.

By end user, the market is categorized into hospitals and clinics, nursing care centers, home care settings, and other end users. In terms of geography, the market is divided into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), South and Central America (Brazil, Argentina, and the Rest of South and Central America), and Middle East and Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East and Africa).  

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com